Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Leick

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Stem Cells|May 15, 2013
Loss of imprinting of IGF2 and the epigenetic progenitor model of cancerMark B Leick, Christopher J Shoff, Erwin C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2022
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated IndividualsKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Leukemia|February 26, 2022
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patientsJoan How, Kathleen M E Gallagher, Yiwen Liu, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Blood Advances|February 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Blood Advances|February 24, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Stealth transgenes enable CAR-T cells to evade host immune responsesKorneel Grauwet, Trisha Berger, Michael C Kann, et al.
Bone Marrow Transplantation|October 11, 2023
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamideDaniel J Ikeda, Zachariah DeFilipp, Kerry Collier, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Stem Cells|May 15, 2013
Loss of imprinting of IGF2 and the epigenetic progenitor model of cancerMark B Leick, Christopher J Shoff, Erwin C Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2022
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated IndividualsKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Leukemia|February 26, 2022
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patientsJoan How, Kathleen M E Gallagher, Yiwen Liu, et al.
The New England Journal of Medicine|March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaBryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Blood Advances|February 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Blood Advances|February 24, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Stealth transgenes enable CAR-T cells to evade host immune responsesKorneel Grauwet, Trisha Berger, Michael C Kann, et al.
Bone Marrow Transplantation|October 11, 2023
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamideDaniel J Ikeda, Zachariah DeFilipp, Kerry Collier, et al.
Pageof 6